Literature DB >> 16300960

Involvement of SLP-65 and Btk in tumor suppression and malignant transformation of pre-B cells.

Rudi W Hendriks1, Rogier Kersseboom.   

Abstract

Signals from the precursor-B cell receptor (pre-BCR) are essential for selection and clonal expansion of pre-B cells that have performed productive immunoglobulin heavy chain V(D)J recombination. In the mouse, the downstream signaling molecules SLP-65 and Btk cooperate to limit proliferation and induce differentiation of pre-B cells, thereby acting as tumor suppressors to prevent pre-B cell leukemia. In contrast, recent observations in human BCR-ABL1(+) pre-B lymphoblastic leukemia cells demonstrate that Btk is constitutively phosphorylated and activated by the BCR-ABL1 fusion protein. As a result, activated Btk transmits survival signals that are essential for the transforming activity of oncogenic Abl tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16300960     DOI: 10.1016/j.smim.2005.10.002

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  11 in total

1.  Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90.

Authors:  Kamalika Moulick; James H Ahn; Hongliang Zong; Anna Rodina; Leandro Cerchietti; Erica M Gomes DaGama; Eloisi Caldas-Lopes; Kristin Beebe; Fabiana Perna; Katerina Hatzi; Ly P Vu; Xinyang Zhao; Danuta Zatorska; Tony Taldone; Peter Smith-Jones; Mary Alpaugh; Steven S Gross; Nagavarakishore Pillarsetty; Thomas Ku; Jason S Lewis; Steven M Larson; Ross Levine; Hediye Erdjument-Bromage; Monica L Guzman; Stephen D Nimer; Ari Melnick; Len Neckers; Gabriela Chiosis
Journal:  Nat Chem Biol       Date:  2011-09-25       Impact factor: 15.040

2.  Development of acute lympboblastic leukemia in a patient with increased hematogones after toxic bone marrow damage.

Authors:  Stefan Gattenlöhner; Hermann Einsele
Journal:  Int J Clin Exp Pathol       Date:  2010-01-30

3.  Bruton's tyrosine kinase (Btk) is a useful marker for Hodgkin and B cell non-Hodgkin lymphoma.

Authors:  Iván Fernández-Vega; Luis M Quirós; Jorge Santos-Juanes; María Pane-Foix; Teresa Marafioti
Journal:  Virchows Arch       Date:  2014-11-30       Impact factor: 4.064

4.  Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK.

Authors:  Ekaterina Kim; Christian Hurtz; Stefan Koehrer; Zhiqiang Wang; Sriram Balasubramanian; Betty Y Chang; Markus Müschen; R Eric Davis; Jan A Burger
Journal:  Blood       Date:  2016-12-28       Impact factor: 22.113

5.  Novel mechanism of tumor suppression by polarity gene discs large 1 (DLG1) revealed in a murine model of pediatric B-ALL.

Authors:  Gabriel J Sandoval; Daniel B Graham; Grzegorz B Gmyrek; Holly M Akilesh; Keiko Fujikawa; Benedicte Sammut; Deepta Bhattacharya; Shuba Srivatsan; Alfred Kim; Andrey S Shaw; Katherine Yang-Iott; Craig H Bassing; Eric Duncavage; Ramnik J Xavier; Wojciech Swat
Journal:  Cancer Immunol Res       Date:  2013-10-07       Impact factor: 11.151

6.  Cutting edge: cell-autonomous control of IL-7 response revealed in a novel stage of precursor B cells.

Authors:  Gabriel J Sandoval; Daniel B Graham; Deepta Bhattacharya; Barry P Sleckman; Ramnik J Xavier; Wojciech Swat
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

7.  The Phospholipase Cγ2 Mutants R665W and L845F Identified in Ibrutinib-resistant Chronic Lymphocytic Leukemia Patients Are Hypersensitive to the Rho GTPase Rac2 Protein.

Authors:  Claudia Walliser; Elisabeth Hermkes; Anja Schade; Sebastian Wiese; Julia Deinzer; Marc Zapatka; Laurent Désiré; Daniel Mertens; Stephan Stilgenbauer; Peter Gierschik
Journal:  J Biol Chem       Date:  2016-08-19       Impact factor: 5.157

8.  Requirement of phosphatidylinositol(3,4,5)trisphosphate in phosphatidylinositol 3-kinase-induced oncogenic transformation.

Authors:  Adam Denley; Marco Gymnopoulos; Sohye Kang; Christina Mitchell; Peter K Vogt
Journal:  Mol Cancer Res       Date:  2009-07-07       Impact factor: 5.852

9.  Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function.

Authors:  Daniel Trageser; Ilaria Iacobucci; Rahul Nahar; Cihangir Duy; Gregor von Levetzow; Lars Klemm; Eugene Park; Wolfgang Schuh; Tanja Gruber; Sebastian Herzog; Yong-mi Kim; Wolf-Karsten Hofmann; Aihong Li; Clelia Tiziana Storlazzi; Hans-Martin Jäck; John Groffen; Giovanni Martinelli; Nora Heisterkamp; Hassan Jumaa; Markus Müschen
Journal:  J Exp Med       Date:  2009-07-20       Impact factor: 14.307

10.  Myc stimulates B lymphocyte differentiation and amplifies calcium signaling.

Authors:  Tania Habib; Heon Park; Mark Tsang; Ignacio Moreno de Alborán; Andrea Nicks; Leslie Wilson; Paul S Knoepfler; Sarah Andrews; David J Rawlings; Robert N Eisenman; Brian M Iritani
Journal:  J Cell Biol       Date:  2007-11-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.